Skip to main content

Table 3 Significant cytokines identified in 29 subjects (15 with Metastasis and 14 without Metastasis)

From: The MK2 pathway is linked to G-CSF, cytokine production and metastasis in gastric cancer: a novel intercorrelation analysis approach

 Analytes*Without metastasis, pg/ml (n = 15)
Median (Q1, Q3)
With metastasis, pg/ml
(n = 15)
Median (Q1, Q3)
Sidak adjusted p-value**Effect size
1GCSF50.8 (38.5–93.2)1612.4 (894.9–2990.8)0.00012
2IL6148.2 (16.1–366.7)5021.7 (3832.1–6510.8)0.00014209
3IL8314.1 (27.1–1758.8)8517.5 (6815.4–11095.9)0.00014209
4MCP1274.9 (158.5–700.5)3348.5 (2093.3–6191.7)0.0006422.3
5IL107.4 (6.3–10.6)103 (18.3–209.7)0.0024511.7
6TNFa4.1 (3.4–6)8.8 (6.6–15.4)0.004309.5
7GMCSF8.8 (6.5–12.4)28.6 (13.5–34.4)0.050444.8
8Mip1a28.4 (9.5–49.6)63.1 (29.8–267.5)0.083024.3
9IL1B5.9 (3.9–7.5)10.9 (6.4–18.1)0.284243.1
10Mip1B12.9 (9.8–15.6)21.2 (13.9–35.2)0.329113.0
11VEGF110.8 (44.3–140)222.3 (80.8–307.5)0.329112.9
12IL74.6 (1–9.1)17.1 (1–24.8)0.573802.4
13IL24 (1.5–4.9)7.5 (1.3–11.8)0.709082.2
14IL49.8 (7.1–11.7)18.9 (0.6–42.7)0.747892.1
15IL_12p4012.1 (6.5–14.6)28.4 (2.8–38.8)0.755982.1
16IFNa221.9 (9.8–34.8)55.9 (4.6–82.7)0.773692.0
17IL17A6.7 (5.2–8.7)12.8 (5.4–17.5)0.802201.9
18TNFB8.4 (5.5–12.4)15 (1.5–24.2)0.872851.8
19IFNg9.8 (7.3–10.6)16.3 (0.4–25.4)0.937821.6
20EGF12.8 (7.5–16.1)14.9 (6.3–25.9)0.965721.5
21IL137.1 (4.8–10.4)9.8 (2.4–13.8)0.988741.3
22IL_12p707.8 (7.2–9.8)10.4 (2.1–17.4)0.988741.3
23IL1a7 (6.5–9.2)8.2 (2.7–13.1)0.991241.2
24IL1510.2 (7.9–14.5)10.2 (3.8–14.1)0.991241.2
25IL54.4 (3.7–5.5)5.4 (0.7–6.7)0.991241.2
26IP1041.9 (26.1–66.7)41 (30–113)0.991241.1
  1. Italic values indicate significance of p < 0.05
  2. *Six significant cytokines identified (total cytokines 26)
  3. **Sidak correction for multiple comparisons for the Kruskal–Wallis test